Inventor · disambiguated record
Chung-Pin H. Chen
Also filed as: CHEN CHUNG-PIN · CHEN CHUNG-PIN H
13 granted patents·8 pending applications·187 citations·filing 1992–2020
93Inventor score
Files withBRISTOL MYERS SQUIBB CO11VIIV HEALTHCARE UK NO 4 LTD5UEDA YASUTSUGU2EISAI CO LTD1SANDOZ LTD1
Top patents by PatentIndex Score
21 records- 0197US7745625B2Prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 29, 2010·62 cites·7 claims
- 0292US8168615B2Prodrugs of piperazine and substituted piperidine antiviral agentsUEDA YASUTSUGU·Filed 2010·Granted May 1, 2012·14 cites·1 claims
- 0391US8461333B2Salts of prodrugs of piperazine and substituted piperidine antiviral agentsUEDA YASUTSUGU·Filed 2012·Granted Jun 11, 2013·12 cites·2 claims
- 0490US7851476B2Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazineBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 14, 2010·16 cites·14 claims
- 0590US6448401B1Process for water soluble azole compoundsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Sep 10, 2002·35 cites·6 claims
- 0687US8871771B2Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 28, 2014·5 cites·1 claims
- 0782US7723338B2Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazineBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 25, 2010·5 cites·12 claims
- 0882US6362172B2Water soluble prodrugs of azole compoundsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 26, 2002·17 cites·18 claims
- 0978US8436168B2Methods of making HIV attachment inhibitor prodrug compound and intermediatesTRIPP JONATHAN CLIVE·Filed 2012·Granted May 7, 2013·10 cites·21 claims
- 1076US11369624B2Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK NO 4 LTD·Filed 2020·Granted Jun 28, 2022·0 cites·1 claims
- 1172US2020046743A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK NO 4 LTD·Filed 2019·Application pending·0 cites
- 1270US2019111066A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK NO 4 LTD·Filed 2018·Application pending·0 cites
- 1369US7034152B2Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta )]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-oneBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Apr 25, 2006·4 cites·40 claims
- 1467US2015025240A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1566US2018000849A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK (NO 4) LTD·Filed 2017·Application pending·0 cites
- 1663US2016361328A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK (NO 4) LTD·Filed 2016·Application pending·0 cites
- 1761US5208352AProcess for preparing the R- and S-isomers of 2-hydroxy-methyl-2-octadecyloxymethyl-tetrahydrofuran and their use in preparing stereoisomers of pharmacologically active compoundsSANDOZ LTD·Filed 1992·Granted May 4, 1993·7 cites·30 claims
- 1861US2015315218A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1961US2015232414A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2057US7550619B2Intermediates in the preparation of the antiviral agent [1S-(1α, 3α, 4β)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxmethyl)-2-methylenecyclopentyl]-6H-purin-6-oneBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 23, 2009·0 cites·8 claims
- 2138US2006264406A1Mono-lysine salts of azole compoundsEISAI CO LTD·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →